These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
527 related articles for article (PubMed ID: 16220833)
1. Immunohistochemical study of neuroendocrine differentiation in primary glandular lesions and tumors of the urinary bladder. Bollito ER; Pacchioni D; Lopez-Beltran A; Volante M; Terrone C; Casetta G; Mari M; DePompa R; Cappia S; Papotti M Anal Quant Cytol Histol; 2005 Aug; 27(4):218-24. PubMed ID: 16220833 [TBL] [Abstract][Full Text] [Related]
2. Malignant glandular lesions and glandular differentiation in invasive/noninvasive urothelial carcinoma of the urinary bladder. Behzatoğlu K Ann Diagn Pathol; 2011 Dec; 15(6):422-6. PubMed ID: 21855380 [TBL] [Abstract][Full Text] [Related]
3. Primary, pure, large-cell neuroendocrine carcinoma of the urinary bladder. Hailemariam S; Gaspert A; Komminoth P; Tamboli P; Amin M Mod Pathol; 1998 Oct; 11(10):1016-20. PubMed ID: 9796733 [TBL] [Abstract][Full Text] [Related]
4. Urachal carcinomas of the nonglandular type: salient features and considerations in pathologic diagnosis. Paner GP; Barkan GA; Mehta V; Sirintrapun SJ; Tsuzuki T; Sebo TJ; Jimenez RE Am J Surg Pathol; 2012 Mar; 36(3):432-42. PubMed ID: 22301493 [TBL] [Abstract][Full Text] [Related]
5. Frequent expression of neuroendocrine markers in mucinous tubular and spindle cell carcinoma of the kidney. Kuroda N; Hes O; Miyazaki E; Shuin T; Enzan H Histol Histopathol; 2006 Jan; 21(1):7-10. PubMed ID: 16267782 [TBL] [Abstract][Full Text] [Related]
6. Distinction of high-grade neuroendocrine carcinoma/small cell carcinoma from conventional urothelial carcinoma of urinary bladder: an immunohistochemical approach. Thompson S; Cioffi-Lavina M; Chapman-Fredricks J; Gomez-Fernandez C; Fernandez-Castro G; Jorda M Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):395-9. PubMed ID: 21617524 [TBL] [Abstract][Full Text] [Related]
7. Urachal carcinoma: a clinicopathologic analysis of 24 cases with outcome correlation. Gopalan A; Sharp DS; Fine SW; Tickoo SK; Herr HW; Reuter VE; Olgac S Am J Surg Pathol; 2009 May; 33(5):659-68. PubMed ID: 19252435 [TBL] [Abstract][Full Text] [Related]
8. Prognostic implications of neuroendocrine differentiation and hormone production in patients with Stage I nonsmall cell lung carcinoma. Pelosi G; Pasini F; Sonzogni A; Maffini F; Maisonneuve P; Iannucci A; Terzi A; De Manzoni G; Bresaola E; Viale G Cancer; 2003 May; 97(10):2487-97. PubMed ID: 12733148 [TBL] [Abstract][Full Text] [Related]
9. Nonsmall cell lung carcinoma with neuroendocrine differentiation--an entity of no clinical or prognostic significance. Ionescu DN; Treaba D; Gilks CB; Leung S; Renouf D; Laskin J; Wood-Baker R; Gown AM Am J Surg Pathol; 2007 Jan; 31(1):26-32. PubMed ID: 17197916 [TBL] [Abstract][Full Text] [Related]
10. [Detection of neuroendocrine differentiation in NSCLC and its clinical significance]. Ouyang N; Chen G; Ding J Zhonghua Jie He He Hu Xi Za Zhi; 2001 Feb; 24(2):90-2. PubMed ID: 11802946 [TBL] [Abstract][Full Text] [Related]
11. Primary mucin-producing urothelial-type adenocarcinoma of prostate: report of 15 cases. Osunkoya AO; Epstein JI Am J Surg Pathol; 2007 Sep; 31(9):1323-9. PubMed ID: 17721186 [TBL] [Abstract][Full Text] [Related]
12. Small cell carcinoma of the uterine cervix--an uncommon variant of cervical cancer with neuroendocrine features. Lenczewski A; Terlikowski S; Sulkowska M; Famulski W; Kisielewski W; Kulikowski M Folia Histochem Cytobiol; 2001; 39 Suppl 2():89-90. PubMed ID: 11820641 [TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation and prognosis in breast adenocarcinoma. Miremadi A; Pinder SE; Lee AH; Bell JA; Paish EC; Wencyk P; Elston CW; Nicholson RI; Blamey RW; Robertson JF; Ellis IO Histopathology; 2002 Mar; 40(3):215-22. PubMed ID: 11895486 [TBL] [Abstract][Full Text] [Related]
14. Small cell carcinoma of urinary bladder is differentiated from urothelial carcinoma by chromogranin expression, absence of CD44 variant 6 expression, a unique pattern of cytokeratin expression, and more intense gamma-enolase expression. Iczkowski KA; Shanks JH; Allsbrook WC; Lopez-Beltran A; Pantazis CG; Collins TR; Wetherington RW; Bostwick DG Histopathology; 1999 Aug; 35(2):150-6. PubMed ID: 10460660 [TBL] [Abstract][Full Text] [Related]
15. Tissue microarray analysis of neuroendocrine differentiation and its prognostic significance in breast cancer. Makretsov N; Gilks CB; Coldman AJ; Hayes M; Huntsman D Hum Pathol; 2003 Oct; 34(10):1001-8. PubMed ID: 14608533 [TBL] [Abstract][Full Text] [Related]
17. Large cell and small cell neuroendocrine bladder carcinoma: immunohistochemical and outcome study in a single institution. Alijo Serrano F; Sánchez-Mora N; Angel Arranz J; Hernández C; Alvarez-Fernández E Am J Clin Pathol; 2007 Nov; 128(5):733-9. PubMed ID: 17951193 [TBL] [Abstract][Full Text] [Related]
18. Small cell neuroendocrine carcinoma of the urinary bladder. An immunohistochemical and ultrastructural evaluation of 3 cases with a review of the literature. Blomjous CE; Thunnissen FB; Vos W; de Voogt HJ; Meijer CJ Virchows Arch A Pathol Anat Histopathol; 1988; 413(6):505-12. PubMed ID: 2849230 [TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis in a morphologic spectrum of urachal epithelial neoplasms: diagnostic implications and pitfalls. Paner GP; McKenney JK; Barkan GA; Yao JL; Frankel WL; Sebo TJ; Shen SS; Jimenez RE Am J Surg Pathol; 2011 Jun; 35(6):787-98. PubMed ID: 21572312 [TBL] [Abstract][Full Text] [Related]
20. [Spindle cell carcinoma of breast with neuroendocrine differentiation]. Ding HY; Gao LX Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):13-7. PubMed ID: 16608642 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]